Skip to content

Sam's News — health — 2026-09-21

Neuroscience

7.5 Needle-Thin Brain Implant Combines Recording, Drug Delivery, and Stimulation

Scientists developed a needle-thin flexible brain implant called the mAxialtrode that simultaneously records neural activity, delivers medication, and stimulates brain regions—three functions previously requiring separate devices. Testing in mice proved successful, with potential applications for studying epilepsy, memory, and neurological disorders.

  • Device combines recording, drug delivery, and stimulation in single implant
  • Made of soft optical fibers to reduce tissue damage
  • Successfully tested in mice
  • Reduces need for multiple inserted devices
  • Still far from clinical use; requires extensive testing and regulatory approval

Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS

7 Human Brain May Have Evolved From Two Distinct Organ Systems

Stanford researchers discovered the human brain develops from two distinct progenitor cell systems rather than one, suggesting evolution fused two ancient nervous systems. The forebrain and midbrain control complex cognition, while the hindbrain manages automatic survival functions and speech-related muscles.

  • Brain develops from two separate progenitor cell populations
  • Forebrain/midbrain: complex thought, language, consciousness
  • Hindbrain: breathing, heartbeat, hunger, facial/throat muscles
  • Hindbrain neurons successfully grown in lab for first time
  • Published in Nature Neuroscience, September 18, 2026

Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS

Health

7.5 FDA approves Eli Lilly breast cancer combination therapy

The FDA approved Eli Lilly's breast cancer combination therapy on September 21 for treating advanced breast cancer.

  • Approved for advanced breast cancer
  • FDA approval date: September 21, 2026

Sources: STAT News AI Web Searched

7 Large review finds calcium and vitamin D supplements provide little fracture prevention benefit in most older adults

A comprehensive review of 69 trials involving nearly 154,000 older adults found that calcium and vitamin D supplements—alone or combined—provide little to no meaningful fracture or fall prevention benefit. The findings challenge routine supplementation recommendations and suggest exercise-based strategies may be more effective.

  • 153,902 adults analyzed across 69 randomized controlled trials
  • High certainty evidence for vitamin D alone (36 trials, 92,045 participants)
  • High certainty evidence for combination therapy (15 trials, 51,126 participants)
  • Published in The BMJ
  • Balance and resistance exercise may be more effective alternatives

Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS, ScienceDaily — Nutrition RSS

7 Chronic Stress-Linked Inflammation May Silently Reshape the Heart

Researchers analyzing nearly 480,000 UK adults found that chronic inflammation linked to stress, lifestyle, and socioeconomic factors silently reshapes heart structure for years before symptoms appear. People with the highest inflammation levels faced a 43% greater cardiovascular risk than those with the lowest.

  • 43% greater heart attack and stroke risk in highest inflammation group
  • Measured via blood marker glycoprotein acetyls (GlycA)
  • Inflammation linked to socioeconomic disadvantage and psychological distress
  • Physical remodeling: thicker walls, smaller chambers, poorer filling
  • Analysis covered nearly 480,000 UK adults

Sources: ScienceDaily AI Web Searched, ScienceDaily — Health RSS

6.5 Alkermes' orexin agonist shows promise for ADHD treatment in early-stage trial

Alkermes reported that an orexin agonist demonstrated potential efficacy for treating ADHD in preliminary clinical testing.

Sources: STAT News RSS

6 Addiction clinics report surge in kratom and 7-OH withdrawal cases

Addiction treatment clinics are seeing rising numbers of patients dependent on potent kratom and 7-hydroxymitragynine products.

Sources: STAT News RSS

Healthcare

7.5 Grail cancer blood test FDA advisory committee vote looms

Grail's stock surged 33% on September 21 following FDA posting of documents ahead of a Wednesday advisory committee meeting on Galleri, its blood-based cancer detection test. FDA approval is expected to facilitate insurance reimbursement.

  • Stock surge: 33% on September 21, 2026
  • Test: Galleri, detects multiple cancer types
  • Expected impact: Improved Medicare and insurance reimbursement
  • Meeting: FDA advisory committee on September 23, 2026

Sources: STAT News AI Web Searched

Health Policy

7 President of the United States repeats vaccine misinformation following RFK Jr. appointment

The president of the United States has reiterated vaccine safety misinformation a day after appointing Robert F. Kennedy Jr. as health secretary.

Sources: STAT News RSS

Pharma

6 Novo Nordisk unveils strategy to expand obesity franchise and diversify pipeline

Under investor pressure, Novo Nordisk outlined plans to grow its obesity drug business while diversifying into direct-to-consumer offerings.

Sources: STAT News RSS